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Abstract It has been found that a recombinant cytochrome P- 
450scc precursor supplemented with an extra MRGSH6GIR se- 
quence at the NH2-terminus (6His-pP450scc) is imported into 
isolated rat liver and heart mitochondria as well as into yeast 
mitochondria. The import is coupled with proteolytic processing 
of the precursor resulting in the mature size form of cytochrome 
P-450scc. Modification of the targeting presequence responsible 
for its increased positive charge is supposed to lift the previously 
suggested tissue-specific restrictions on the pP450scc import into 
mitochondria. 
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I. Introduction 
The mechanisms of import of cytoplasmically made mito- 
chondrial proteins into mitochondria nd those of their prote- 
olytic processing inside the organelles were intensively studied 
over the last 20 years. According to the data obtained, such 
proteins are usually synthesized as precursors upplied with a 
specific amino acid sequence at the NHz-terminus which pro- 
vides their targeting to mitochondria nd location in one or 
another compartment of the organelle [1,2]. These targeting 
presequences were considered to be universal, i.e. operating 
with no tissue or species specificity [3-5]. In a few cases, how- 
ever, heterologous import of  protein precursors into mitochon- 
dria did not occur. This is particularly true of the precursor of 
cytochrome P-450scc, an integral protein of the inner mem- 
brane of adrenal cortex mitochondria. The above protein is a 
member of the cholesterol hydroxylating system specific to 
mitochondria of  mammalian steroidogenic tissues. It has been 
shown that bovine import-competent heart mitochondria can 
bind the cytochrome P-450scc precursor but fail to import and 
process the protein [6,7]. Establishing the nature of the tissue 
specificity of the above processes help one to achieve further 
progress in understanding their mechanisms. 
*Corresponding author. Fax: (7) (095) 939 31 81. 
Abbreviations." pP450scc, precursor of cytochrome P-450scc; 6His- 
pP450scc, modified form of the cytochrome P-450scc precursor ex- 
pressed in Escherichia coli; Ni-NTA agarose, agarose linked with Ni 2+ 
nitrilo-tri-acetate. 
This study demonstrates that modification of the bovine cy- 
tochrome P-450scc precursor by linking the MetArgGlySer- 
His6GlyIleArg sequence to its NH2-terminus results in the im- 
port of the recombinant protein into rat heart mitochondria, 
the precursor being processed to the mature size form there- 
with. 
Import and processing of 6His-pP450scc were also observed 
in the experiments on rat liver and yeast mitochondria. The 
data obtained suggest hat tissue-specific restrictions on these 
processes can be lifted by modification of the targeting prese- 
quence of the cytochrome P-450scc precursor. 
2. Materials and methods 
The QIAexpress ystem for synthesis and isolation of recombinant 
proteins (QIAgen, Germany) was used in this work. The system in- 
cludes the pQE plasmid and E. coli cells, strain SG13009[pREP4] and 
Ni-NTA agarose. The expressing vector was constructed by ligation of 
the pQE plasmid, restricted at the SphI/KpnI site in the polylinker 
region, and a SphI/KpnI fragment of the pCD plasmid containing 
cDNA for cytochrome P-450scc [8]. The His 6 block was located at the 
NH2-terminus of the recombinant pP450scc. Expression of cDNA en- 
coding 6His-pP450scc was induced by isopropyl fl-D-thiogalactopyra- 
noside (final concentration 1 mM) and continued for 5 h at 30°C. Cell 
fractionation as well as purification on a column containing Ni-NTA 
agarose and renaturation of 6His-pP450scc were performed as in [9]. 
Import of the purified 6His-pP450scc into isolated mitochondria was 
carried out according to [10] with minor modifications. The samples for 
import (200 ¢tl) contained 10 mM MOPS (pH 7.4), 0.25 M mannitol, 
50 mM KCI, 2 mM ATE 2 mM GTP, 10 mM ADP, 3 mM K2HPO4, 
1 mM DTT, 2 mM magnesium acetate, 5 mM sodium succinate, 1% 
(m/v) BSA, rabbit reticulocyte lysate (5%, v/v), isolated mitochondria 
(20/zg) and 6His-pP450scc (8/zg). The import was continued for 30 rain, 
then the sample was divided in two and one of the aliquotes was treated 
with pronase K (100/lg/ml, 30 rain, 0°C) afterwards. The action of 
pronase K was interrupted by adding phenylmethylsulfonyl fluoride 
(final concentration 2 mM). Mitochondria were sedimented by centrif- 
ugation (15,000 x g, 20 min) and the pellets were analyzed by im- 
munoblotting. 
The protein concentration was measured after Lowry [11] using BSA 
as a standard. SDS-PAGE was performed according to Laemmli [12] 
in lC~12.5% PAG. Immunoblotting was carried out as described in [13] 
using consecutively the IgG fraction ofanti-P450scc antiserum, a conju- 
gate of anti-rabbit antibodies with horse-radish peroxidase, and a per- 
oxidase substrate (o-dianisidine). 
Cytochrome P-450scc from bovine adrenal cortex and anti-cyto- 
chrome P-450scc antibodies were a generous gift of Dr. S.A. Usanov 
(Institute of Bioorganic Chemistry, Academy of Sciences of Belarus, 
Minsk). The rabbit reticulocyte lysate was supplied by Dr. O.N. Den- 
isenko (Institute of Protein Research, Pushchino). The conjugate of 
anti-rabbit antibodies with horse-radish peroxidase was purchased 
from Agro-Bio (Moscow). Yeast mitochondria were isolated from Can- 
dida valida cells according to [14]. 
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3. Results and discussion 
Fig. 1 shows targeting presequence of a modified form of the 
bovine cytochrome P-450scc precursor. The presence of the 
histidine block at the NH2-terminus of 6His-pP450scc allows 
one to isolate and to deal selectively with a protein containing 
a modified presequence. 
It has earlier been shown [15] that pP450scc an be imported 
into isolated rat liver mitochondria taking part in steroid me- 
tabolism. To verify whether extra amino acid residues in the 
NH2-presequence of 6His-pP450scc are capable of affecting its 
targeting properties, a similar experiment was carried out with 
the recombinant protein. As follows from Fig. 2, incubation of 
6His-pP450scc (55 kDa) with rat liver mitochondria results in 
the import of the protein precursor into organelles and in the 
mature size form of cytochrome P-450scc (molecular mass of 
51 kDa). Newly formed mature P-450scc detectable by im- 
munoblotting has nearly the same molecular mass as cyto- 
chrome P-450 isolated from bovine adrenal cortex (Fig. 2, lanes 
3 and 5). The intramitochondrial location of the mature P- 
450scc is evidenced by its insensitivity to exogenous pronase K 
while its precursor (i.e. 6His-pP450scc) suffers proteolysis 
(Fig.2, lanes 2 and 3). Thus, the above results suggest that the 
extra MetArgGlySerHis6GlyIleArg sequence at the NH2-termi- 
nus of the polypeptide chain does not impede the import and 
processing of the cytochrome P-450scc precursor. 
It follows from the literature data that import of a variety of 
protein precursors into mitochondria and their processing are 
not tissue- and species-specific. However, taking into account 
the fact that bovine heart mitochondria fail to import the in 
vitro synthesized precursor of cytochrome P-450scc normally 
located in adrenal cortex mitochondria [7,8], it has been sug- 
gested that pP450scc an be imported only into mitochondria 
of steroidogenic tissues. As steroid hydroxylation system in- 
cluding cytochrome P-450scc exists in selected tissues only, it 
was not impossible that mitochondria of specialized ster- 
oidogenic organs have a unique translocation apparatus and 
enzymes (maturases) that are necessary for import and process- 
ing of pP450scc. 
In this context it was of interest o find out whether the 
contention that the import of pP450scc is tissue-specific has 
some relation to its modified form, i.e. to 6His-pP450scc. We 
studied the heterologous import of 6His-pP450scc into isolated 
rat heart and yeast mitocbondria. As Fig. 3 shows, 6His- 
pP450scc is imported by both heterologous organelles which is 
evidenced by the appearance of a mature size form of the 
protein and by insensitivity of the latter to added pronase K 
(Fig. 3a,b, lanes 3). As in the experiments with rat liver mito- 
chondria, the electrophoretic mobility of processed P450scc 
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Fig. 1. Primary structure of the modified presequence of the recombi- 
nant cytochrome P-450scc precursor. The arrow shows the beginning 
of the native presequence. The sequence of mature cytochrome 
P-450scc is boxed. 
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1 2 3 4 5 
Fig. 2. Import of 6His-pP450scc into rat liver mitochondria. The sam- 
ples were analyzed by immunoblotting: (1) control sample, without 
6His-pP450scc; (2,3) imported protein prior to (2) and after (3) treat- 
ment with pronase K; (4) 6His-pP450scc isolated from E. coli cells; 
(5) cytochrome P-450scc from bovine adrenal cortex mitochondria. 
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Fig. 3. Import of 6His-pP450scc into rat heart (a) and yeast (b) mito- 
chondria. The samples were analyzed by immunoblotting: (1) 6His- 
pP450scc isolated from E. coli and mature P-450scc from bovine adre- 
nal cortex; (2,3) import of 6His-pP450scc, the samples prior to (2) and 
after (3) the treatment with pronase K; (4) control sample without 
6His-pP450scc. 
corresponded to that of cytochrome P-450scc prepared from 
bovine adrenal cortex (Fig. 3a,b, lanes 1 and 3). One should 
emphasize that the import into rat heart mitochondria was 
almost as effective as that into rat liver and yeast mitochondria. 
Consequently, the point that the import of pP450scc into mito- 
chondria is tissue-specific bears no relation to its modified form 
6His-pP450scc. 
The mitochondrial targeting presequence is known to have 
a high content of positively charged amino acid residues [16]. 
Perhaps, attachment of the MetArgGlySerHis6GlylleArg f ag- 
ment, enriched in such residues, to the NH2-terminus of the 
polypeptide chain could facilitate the penetration of the modi- 
fied presequence into mitochondria. In other words, a selective 
barrier for protein precursors realized in mitochondria of ster- 
oidogenic organs due to putative tissue-specific receptors or the 
unique lipid composition of mitochondrial membranes, can be 
surmounted by modification of the targeting presequenee of a 
precursor to be imported. 
By and large, our experiments estify that 6His-pP450scc is
capable of penetrating into heterologous mitochondria of vari- 
ous organs (rat heart and rat liver) and into yeast mitochondria. 
The imported protein suffers proteolytic processing in these 
mitochondria just as in homologous mitochondria. It has ear- 
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lier been shown that nonmodified bovine pP450scc synthesized 
in an in vitro transcription-translation system is imported into 
isolated mitochondria of soybean cotyledons [17]. All these 
results suggest hat the capacity for import and processing of 
pP450scc is not inherent exclusively in mitochondria of ster- 
oidogenic organs. Crucial moments in these processes are 
hardly a unique mechanism of transmembrane translocation 
and the presence of a unique maturase. Both import and proc- 
essing are rather predetermined by the structure of a protein 
precursor and specifically by the targeting presequence. 
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